ROR1 and neoplasm: Concordantly, in a PDX model for Richter’s syndrome, a rare complication of CLL resulting in transformation towards an even more aggressive form of lymphoma, VLS-101 demonstrated a high specificity towards ROR1 by reaching tumor cells in peripheral blood, bone marrow, and spleen, leading to significant disease regression.